Home/Filings/4/0001109357-25-000028
4//SEC Filing

Kleczynski Robert A 4

Accession 0001109357-25-000028

CIK 0001109357other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 5:14 PM ET

Size

29.0 KB

Accession

0001109357-25-000028

Insider Transaction Report

Form 4
Period: 2025-02-03
Kleczynski Robert A
SVP, Controller & Tax
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-03+1,23324,272 total
  • Disposition to Issuer

    Common Stock

    2025-02-03$40.57/sh2,032$82,43827,927 total
  • Exercise/Conversion

    2023 Restricted Stock Units

    2025-02-031,4221,421 total
    Common Stock (1,422 underlying)
  • Award

    2025 Restricted Stock Units

    2025-02-03+6,1016,101 total
    Common Stock (6,101 underlying)
  • Exercise/Conversion

    2024 Restricted Stock Units

    2025-02-031,6243,246 total
    Common Stock (1,624 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-03+1,42225,694 total
  • Exercise/Conversion

    2022 Restricted Stock Units

    2025-02-031,2330 total
    Common Stock (1,233 underlying)
  • Award

    2022-2024 Performance Shares

    2025-02-03+5,7495,749 total
    Common Stock (5,749 underlying)
  • Exercise/Conversion

    2022-2024 Performance Shares

    2025-02-035,7490 total
    Common Stock (5,749 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-03+5,74933,067 total
  • Exercise/Conversion

    Common Stock

    2025-02-03+1,62427,318 total
  • Tax Payment

    Common Stock

    2025-02-03$40.57/sh3,108$126,09229,959 total
Holdings
  • Deferred phantom share equivalents

    Common Stock (1,736 underlying)
    1,736
  • Retention RSUs

    Common Stock (22,258 underlying)
    22,258
Footnotes (9)
  • [F1]Restricted stock unit (RSU) award granted under the Exelon Long-Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Talent Management and Compensation Committee (TMCC) with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment, and the additional RSUs vest on the same schedule as the underlying award.
  • [F2]Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the TMCC's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the LTIP's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date.
  • [F3]Balance at the time of this vesting includes 49 additional shares acquired through automatic dividend reinvestment during 2024.
  • [F4]Balance at the time of this vesting includes 113 additional shares acquired through automatic dividend reinvestment during 2024.
  • [F5]Balance at the time of this vesting includes 194 additional shares acquired through automatic dividend reinvestment during 2024.
  • [F6]Restricted stock unit (RSU) award granted under the Exelon LTIP on February 25, 2022. Each RSU represents the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award. The award will cliff vest on February 25, 2025.
  • [F7]Balance includes 887 additional shares acquired through automatic dividend reinvestment during 2024.
  • [F8]Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.
  • [F9]Balance as of January 31, 2025. Balance includes 65 additional phantom share equivalents acquired during 2024 through automatic dividend reinvestment.

Issuer

EXELON CORP

CIK 0001109357

Entity typeother

Related Parties

1
  • filerCIK 0001982165

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:14 PM ET
Size
29.0 KB